Trust Investment Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-2,245
Closed -$546K 93
2017
Q2
$546K Sell
2,245
-100
-4% -$23.5K 0.59% 69
2017
Q1
$560K Buy
2,345
+196
+9% +$45.6K 0.6% 67
2016
Q4
$451K Sell
2,149
-365
-15% -$75.6K 0.51% 70
2016
Q3
$579K Buy
2,514
+50
+2% +$12.2K 0.66% 65
2016
Q2
$569K Buy
2,464
+100
+4% +$23.1K 0.67% 64
2016
Q1
$634K Buy
2,364
+159
+7% +$45.5K 0.71% 61
2015
Q4
$689K Buy
2,205
+100
+5% +$29.8K 0.83% 53
2015
Q3
$572K Hold
2,105
0.65% 60
2015
Q2
$639K Sell
2,105
-255
-11% -$76.1K 0.65% 62
2015
Q1
$702K Buy
2,360
+100
+4% +$28.5K 0.7% 60
2014
Q4
$582K Sell
2,260
-225
-9% -$56.2K 0.59% 66
2014
Q3
$600K Sell
2,485
-50
-2% -$11.2K 0.58% 67
2014
Q2
$565K Buy
2,535
+250
+11% +$51.8K 0.54% 73
2014
Q1
$470K Sell
2,285
-2,465
-52% -$488K 0.47% 84
2013
Q4
$798K Buy
+4,750
New +$743K 0.82% 55

Other funds holding AGN

Trust Investment Advisors's AGN Position: Q3 2017 in Review

Trust Investment Advisors sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 2,245 shares — an estimated $546K sold.

Trust Investment Advisors first reported a position in AGN in Q4 2013 and held it in 15 quarters. The position peaked at $798K in Q4 2013. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

  • Trust Investment Advisors reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
  • Trust Investment Advisors sold 2,245 Allergan plc shares in Q3 2017, an estimated $546K.
  • Trust Investment Advisors first reported a position in Allergan plc in Q4 2013 and held it in 15 quarters.
  • Trust Investment Advisors's Allergan plc position peaked at $798K in Q4 2013.
  • 1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Trust Investment Advisors's 13F filing for Q3 2017, filed 6 Nov 2017.